APA (7th ed.) Citation

Q, Z., J, Z., S, L., D, C., H, X., Y, Z., . . . L, W. (2024). Vemurafenib induces senescence in acute myeloid leukemia and myelodysplastic syndrome by activating the HIPPO signaling pathway: Implications for potential targeted therapy. Biology direct, 19(1), 6. https://doi.org/10.1186/s13062-023-00451-0

Chicago Style (17th ed.) Citation

Q, Zhou, et al. "Vemurafenib Induces Senescence in Acute Myeloid Leukemia and Myelodysplastic Syndrome by Activating the HIPPO Signaling Pathway: Implications for Potential Targeted Therapy." Biology Direct 19, no. 1 (2024): 6. https://doi.org/10.1186/s13062-023-00451-0.

MLA (9th ed.) Citation

Q, Zhou, et al. "Vemurafenib Induces Senescence in Acute Myeloid Leukemia and Myelodysplastic Syndrome by Activating the HIPPO Signaling Pathway: Implications for Potential Targeted Therapy." Biology Direct, vol. 19, no. 1, 2024, p. 6, https://doi.org/10.1186/s13062-023-00451-0.